Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0001140361-24-033600

Chief Legal Officer gave up 558 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Miller Mary Chief Legal Officer 2024-07-17 Shares withheld for taxes −558 $7.69 $4,291 39,151 D: show line 1 in the form
Loading xslF345X05/form4.xml…